Intermolecular (IMI) Tops Q2 EPS by 2c

Intermolecular (NASDAQ: IMI) reported Q2 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $8.1 million versus the consensus estimate of $8 million.

For earnings history and earnings-related data on Intermolecular (IMI) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Park Dental Partners, Inc. (PARK) Tops Q2 EPS by 28c
• Aptera Motors (SEV) Reports Q2 Loss of $0.20